[HTML][HTML] Old muscle, new tricks: a clinician perspective on sarcopenia and where to next
K Schütze, M Schopp, TJ Fairchild… - Current opinion in …, 2023 - journals.lww.com
Old muscle, new tricks: a clinician perspective on sarcopeni... : Current Opinion in Neurology
Old muscle, new tricks: a clinician perspective on sarcopenia and where to next : Current …
Old muscle, new tricks: a clinician perspective on sarcopenia and where to next : Current …
[HTML][HTML] Senescent fibro-adipogenic progenitors are potential drivers of pathology in inclusion body myositis
C Nelke, CB Schroeter, L Theissen, C Preusse… - Acta …, 2023 - Springer
Inclusion body myositis (IBM) is unique across the spectrum of idiopathic inflammatory
myopathies (IIM) due to its distinct clinical presentation and refractoriness to current …
myopathies (IIM) due to its distinct clinical presentation and refractoriness to current …
[HTML][HTML] Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
PM Machado, MP McDermott, T Blaettler… - The Lancet …, 2023 - thelancet.com
Background Inclusion body myositis is the most common progressive muscle wasting
disease in people older than 50 years, with no effective drug treatment. Arimoclomol is an …
disease in people older than 50 years, with no effective drug treatment. Arimoclomol is an …
[HTML][HTML] Inclusion body myositis, viral infections, and TDP-43: a narrative review
V Văcăraş, R Vulturar, A Chiş, L Damian - Clinical and Experimental …, 2024 - Springer
The ubiquitous RNA-processing molecule TDP-43 is involved in neuromuscular diseases
such as inclusion body myositis, a late-onset acquired inflammatory myopathy. TDP-43 …
such as inclusion body myositis, a late-onset acquired inflammatory myopathy. TDP-43 …
Identification of distinct immune signatures in inclusion body myositis by peripheral blood immunophenotyping using machine learning models
E McLeish, A Sooda, N Slater, K Beer… - Clinical & …, 2024 - Wiley Online Library
Objective Inclusion body myositis (IBM) is a progressive late‐onset muscle disease
characterised by preferential weakness of quadriceps femoris and finger flexors, with elusive …
characterised by preferential weakness of quadriceps femoris and finger flexors, with elusive …
[HTML][HTML] Inmunosenescencia y autoinmunidad: Mecanismos e implicaciones patológicas
AD Ibarra, J Criado-Villamizar, M Niebles-Navas… - Medicina, 2024 - revistamedicina.net
Las enfermedades autoinmunes son trastornos crónicos caracterizados por la respuesta
inmune del cuerpo contra sus propios tejidos, lo que causa inflamación y daño tisular. La …
inmune del cuerpo contra sus propios tejidos, lo que causa inflamación y daño tisular. La …
Understanding Complex Care Situations of Neuromuscular Diseases: Patient-Reported Measures, Cost-of-Illness and Status Quo of Telemedicine
K Senn - 2024 - epub.uni-bayreuth.de
Abstract Der zentrale Fokus der Versorgungsforschung (VSF) ist die tatsächliche
Versorgungssituation und Outcomes von Patient* innen unter Alltagsbedingungen zu …
Versorgungssituation und Outcomes von Patient* innen unter Alltagsbedingungen zu …
[PDF][PDF] Osmolytes and their therapeutic applicability in the mdx mouse
C Merckx - 2023 - biblio.ugent.be
The human body comprises more than 600 different skeletal muscles, which account for
approximately 40-50% of the total body weight [1-3]. The morphology and length of skeletal …
approximately 40-50% of the total body weight [1-3]. The morphology and length of skeletal …
[HTML][HTML] Inmunosenescencia y autoinmunidad: Mecanismos e implicaciones patológicas Immunosenescence and autoimmunity: Mechanisms and Pathological …
A David-Ibarra¹, J Criado-Villamizar¹… - revistamedicina.net
Las enfermedades autoinmunes son trastornos crónicos caracterizados por la respuesta
inmune del cuerpo contra sus propios tejidos, lo que causa inflamación y daño tisular. La …
inmune del cuerpo contra sus propios tejidos, lo que causa inflamación y daño tisular. La …